Atlas Trials

Diet-drive Gut Microbiome and Outcome in Patients With Early-stage Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy and Immunotherapy.

Clinical trial NCT07551765 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07551765
Sponsor
Barts & The London NHS Trust
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Triple Negative Breast Cancer (TNBC), Early Setting
Start date
2026-11-13
Primary completion
2032-11-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.